6 Recruiting Trials

Clinical Trials
for COPD in Washington

6 clinical trials for COPD are currently recruiting participants at study sites in Washington. Study-related care is provided at no cost.

6
Recruiting trials
7
Study sites
4
Cities
4
Industry-sponsored
3
Phase 2
2
Phase 3

COPD clinical trials in Washington: what to expect

COPD trials test new inhaler combinations, biologic injections for people whose flare-ups continue despite inhalers, and treatments for the cough and mucus that come with chronic bronchitis. Others study pulmonary rehabilitation and exercise, valves and other procedures for emphysema, home oxygen and remote monitoring, and programs to stop smoking. Most enroll people with moderate to severe disease who still have symptoms on their current treatment.

In Washington, recruiting copd studies are concentrated in Seattle, Spokane, Everett and Kirkland. 4 of the 6 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who COPD trials usually look for

Trials confirm COPD with a breathing test at screening and set a range for lung function, usually between 30 and 80 percent of predicted. Most ask for a smoking history of at least ten pack-years, though current smokers are generally accepted. Biologic trials require one or two flare-ups in the past year needing steroids or antibiotics and sometimes a blood eosinophil count above a threshold. Common exclusions are asthma as the main diagnosis, another significant lung disease and a flare-up in the past four weeks. Ages are usually 40 to 80.

What taking part involves

Screening includes spirometry, blood work and a symptom questionnaire, then a short run-in while you record symptoms. Drug trials run six to twelve months with visits every four to twelve weeks, breathing tests, a six-minute walk in some, and a diary or app. Your maintenance inhalers continue, sometimes replaced by study-supplied versions, and rescue inhaler is always allowed. Rehabilitation trials involve two or three sessions a week for eight to twelve weeks. Study care is free and visits are usually paid.

Questions worth asking the study team

Whether your inhalers stay the same; how breathing tests and walking tests are scheduled; the chance of placebo; what to do during a flare-up while enrolled; and whether oxygen users are accepted.

Showing 6 of 6 recruiting COPD trials in Washington

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
PHASE3 Birmingham, Alabama +4 sites NCT06878261
This trial is looking for adults aged 40 to 80 who have had COPD for at least a year. Participants will take the study drug Tezepelumab and be monitored for its effects on their condition.
Recruiting
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
PHASE2 Birmingham, Alabama +4 sites NCT07059091
This trial is looking for individuals with Chronic Obstructive Pulmonary Disease (COPD) and allergies. Participants will take a medication called omalizumab for about a year and have follow-up calls afterwards.
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
PHASE3 Athens, Alabama +4 sites NCT06283966
This trial is looking for adults aged 40 to 80 with Chronic Obstructive Pulmonary Disease (COPD). Participants will receive a combination inhaler treatment and attend study visits for assessments.
Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
PHASE2 Miami, Florida +4 sites NCT07725939
This trial is looking for adults aged 40 to 80 with moderate-to-severe chronic obstructive pulmonary disease (COPD) and chronic bronchitis. Participants will take a medication called galvokimig and be monitored for breathing issues over several months.
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
PHASE2 Birmingham, Alabama +4 sites NCT07759245
This trial is looking for adults with moderate-to-severe COPD to test a new treatment called Brenipatide. Participants will receive either the treatment or a placebo and will be monitored for about one year.
Recruiting
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
NA Seattle, Washington +4 sites NCT06390345
This trial is looking for overweight or obese patients who have Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA). If you participate, you will receive a telehealth program that includes lifestyle coaching and exercise guidance over 12 months.
Recruiting

Where the COPD studies are in Washington

  • Copd01 50013, Seattle1 trial
  • Mann-Grandstaff VA Medical Center, Spokane1 trial
  • Pacific Northwest Airways - VA Puget Sound Healthcare System, Seattle, Seattle1 trial
  • Paramount Clinical Research - Data Point Clinical Research, Kirkland1 trial
  • Research Site, Spokane1 trial
  • Research Site, Everett1 trial

Counts are recruiting studies listing at least one site in Washington, from ClinicalTrials.gov, refreshed every two days.

COPD clinical trials in Washington: common questions

How many COPD clinical trials are recruiting in Washington?
TrialFinder currently lists 6 recruiting COPD clinical trials with study sites in Washington. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are COPD clinical trials located in Washington?
Study sites for the COPD trials listed on this page include Seattle. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a COPD clinical trial in Washington?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many COPD trials in Washington also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a COPD clinical trial in Washington?
Each study sets its own criteria based on age, COPD diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I need to quit smoking to join a COPD trial?
Most COPD trials accept current smokers; some require that you have stopped, and smoking-cessation trials are specifically for people who still smoke. The listing states the rule.
What tests confirm COPD for a trial?
Spirometry, a breathing test done at the site before and after a bronchodilator, which gives the lung function figure trials use to set their range. You do not need recent results to ask.
Will I keep using my inhalers during a trial?
Yes. Trials add the study treatment to your maintenance inhalers or supply a standardized equivalent, and a rescue inhaler is always permitted.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to COPD trials near you in Washington.

Get Matched — Free
No insurance required

COPD trials investigate bronchodilators, anti-inflammatory biologics, pulmonary rehabilitation, and lung-volume reduction procedures for chronic obstructive lung disease.

All COPD trials →